Bimosiamose Disodium is a Pan-selectin antagonist developed for the treatment of acute and chronic inflammatory disorders. References: Meyer M, Jilma B, Zahlten R, Wolff G. Physiochemical properties, safety and pharmacokinetics of bimosiamose disodium after intravenous administration. Int J Clin Pharmacol Ther. 2005 Oct;43(10):463-71. PubMed PMID: 16240703.

纯度：≥98%

CAS：187269-60-9